S3 Fig -

(A-B) HFFs were infected with HSV-1 (MOI 1 PFU/cell) and then treated with increasing concentrations of AFM30a (A), GSK199 (B) and CAY10727 (C), which were given 1 h prior to virus adsorption and kept throughout the whole experiment. At 24 hpi, viral plaques were microscopically counted, and the number of plaques was plotted as a function of inhibitor concentration. Values are expressed as means ± SEM (error bars) of three independent experiments, *P P P C-E) Uninfected HFF, SHSY-5Y, ARPE-19 or HEK293 cells were treated with the indicated concentrations of HF4 (C), CAY10727 (D), AFM30a, or GSK199 (E) for 24 h and the number of viable cells was determined for each concentration by MTT assay. Values are expressed as means ± SEM of three independent experiments. (TIF)